Ventyx Biosciences, Inc.
VTYX
Revenue
0.00
0.000.00%
-Assets
309.19M
▼-22.89M▼-6.89%
3 Months ChangeLiabilities
28.40M
▲3.32M▲13.22%
3 Months ChangeFree Cash Flow
-47.80M
▼-16.82M▼-54.29%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-23
Form 8-K
ID: 0001193125-24-223292
2024-08-30
Form 8-K
ID: 0001193125-24-210399
2024-08-08
Form 10-Q
ID: 0000950170-24-094007
2024-08-08
Form 8-K
ID: 0000950170-24-093906
2024-06-06
Form 8-K
ID: 0001193125-24-156047
2024-06-05
Form 8-K
ID: 0001193125-24-155147
2024-05-16
Form 8-K
ID: 0001193125-24-140054
2024-05-09
Form 10-Q
ID: 0000950170-24-057003
2024-05-09
Form 8-K
ID: 0000950170-24-056914
2024-04-05
Form 8-K
ID: 0001193125-24-088624